Patients with hip fracture should be treated earlier

Patients with broken hips should be treated earlier and have surgery on the same day or the day after being admitted to hospital, says NICE. Currently, some patients have to wait several days before receiving surgery, during which time they can be left in pain and suffer complications.

Approval for new rheumatoid arthritis drug

NICE has recommended the use of the drug golimumab (Simponi) as an option for treating rheumatoid arthritis. Golimumab in combination with methotrexate is recommended for adults whose rheumatoid arthritis has responded inadequately to conventional disease-modifying antirheumatic drugs (DMARDs) only.

NICE guideline process earns international praise

NICE guidelines are among the most "trustworthy" in the world and meet a series of rigorous standards, a leading journal has concluded. An editorial published in the US journal Annals of Internal Medicine praises NICE for the way in which it produces its guidance. The journal now plans to publish future NICE guidelines so that they can reach a wider audience.

GPs following NICE LUTS guidance

Nearly half of GPs are following NICE advice on the management of lower urinary tract symptoms (LUTS) in men, one year on from the launch of the guideline, a survey has found. The survey, involving 201 GPs, found that of the 46 per cent of GPs who were following the NICE guideline, 41 per cent said that they had greater confidence in conducting the necessary diagnostic tests.

NICE costing tools can help you implement our guidance

NICE produces costing tools to help you estimate the local cost of implementing our guidance, and build a business case for following our recommendations.The tools are normally published for each technology appraisal, quality standard, medical technology, diagnostic technology, clinical guideline and public health guidance.

NICE is consulting on the proposed programme manual for its new Diagnostics Assessment Programme. The manual has been developed with input from a number of individuals and organisations in the NHS, the diagnostics industry, academia and the Department of Health.

Have your say on a draft scope for the development of a clinical guideline on osteoporosis fragility fracture risk. It is estimated that fragility fractures cost the UK healthcare economy £1.8 billion in 2000, with the potential to increase to £2.2 billion by 2025.

NHS Evidence consults on new Process and Methods Manual

The new manual describes how new and important evidence is made available to users through NHS Evidence.Click here to have your say.

Follow us on Twitter!

Follow NICEcomms for all the latest news.